{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:20:43Z","timestamp":1787026843476,"version":"build-2736575974"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:00:00Z","timestamp":1721174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>In the past three decades, significant improvements have occurred in the study of Duchenne muscular dystrophy (DMD). DMD is a rare, severe neuromuscular disease that causes death due to cardiovascular and respiratory complications among affected boys. Since the 1980s, ongoing preclinical and clinical studies have been conducted to explore the disease in depth and discover potential therapeutic strategies. In Saudi Arabia, it is unclear whether health services and research efforts are keeping pace with global achievements. Therefore, this review aims to explore the diagnostic and management strategies and research efforts in Saudi Arabia over the past three decades. I searched the PubMed\/Medline, Scopus, and Web of Science databases and included all published articles on the epidemiology, genetics, diagnosis, and management of DMD\/BMD in this review. The findings suggest a lack of local standardized diagnostic strategies, a poor understanding of epidemiology and common pathogenic variants, and a critical need for preclinical and clinical research. At the time of writing, no such comprehensive review has been published. Challenges, limitations, and future perspectives are also discussed in this article.<\/jats:p>","DOI":"10.3389\/fneur.2024.1392274","type":"journal-article","created":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:27:50Z","timestamp":1721176070000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Duchenne muscular dystrophy in Saudi Arabia: a review of the current literature"],"prefix":"10.3389","volume":"15","author":[{"given":"Hitham","family":"Aldharee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,17]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/978-3-319-17362-7_2","article-title":"Muscular dystrophy: historical background and types","volume-title":"Muscular Dystrophy: A Concise Guide","author":"Huml","year":"2015"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11897-020-00456-0","article-title":"Duchenne muscular dystrophy: the heart of the matter","volume":"17","author":"Shih","year":"2020","journal-title":"Curr Heart Fail Rep"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1089\/hum.2018.151","article-title":"Gene and Cell therapy for muscular dystrophies: are we getting there?","volume":"29","author":"Galli","year":"2018","journal-title":"Hum Gene Ther"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"4560","DOI":"10.1016\/S0021-9258(19)39599-7","article-title":"Detailed analysis of the repeat domain of dystrophin reveals four potential hinge segments that may confer flexibility","volume":"265","author":"Koenig","year":"1990","journal-title":"J Biol Chem"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.bbamem.2013.08.023","article-title":"Dystrophin complex functions as a scaffold for signalling proteins","volume":"1838","author":"Constantin","year":"2014","journal-title":"BBA-Biomembranes"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1002\/cphy.c140048","article-title":"The dystrophin complex: structure, function, and implications for therapy","volume":"5","author":"Gao","year":"2015","journal-title":"Compr Physiol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1017\/erm.2014.17","article-title":"Dysregulation of calcium homeostasis in muscular dystrophies","volume":"16","author":"Vallejo-Illarramendi","year":"2014","journal-title":"Expert Rev Mol Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.biocel.2010.11.005","article-title":"Duchenne muscular dystrophy \u2013 what causes the increased membrane permeability in skeletal muscle?","volume":"43","author":"Allen","year":"2011","journal-title":"Int J Biochem Cell Biol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/0092-8674(91)90035-W","article-title":"Membrane organization of the dystrophin-glycoprotein complex","volume":"66","author":"Ervasti","year":"1991","journal-title":"Cell"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1177\/0192623317734823","article-title":"Duchenne and Becker muscular dystrophies: a review of animal models, clinical end points, and biomarker quantification","volume":"45","author":"Wilson","year":"2017","journal-title":"Toxicol Pathol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/genes11080837","article-title":"Therapeutic strategies for duchenne muscular dystrophy: an update","volume":"11","author":"Sun","year":"2020","journal-title":"Genes (Basel)"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S1474-4422(18)30024-3","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.rehab.2013.06.002","article-title":"Evolution of life expectancy of patients with Duchenne muscular dystrophy at AFM Yolaine de Kepper Centre between 1981 and 2011","volume":"56","author":"Kieny","year":"2013","journal-title":"Ann Phys Rehabil Med"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/mgg3.97","article-title":"Genetics and genomic medicine in Saudi Arabia","volume":"2","author":"Alkuraya","year":"2014","journal-title":"Mol Genet Genomic Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"629549","DOI":"10.3389\/fped.2021.629549","article-title":"Consensus statement on the Management of Duchenne Muscular Dystrophy in Saudi Arabia during the coronavirus disease 2019 pandemic","volume":"9","author":"Bamaga","year":"2021","journal-title":"Front Pediatr"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"716424","DOI":"10.3389\/fped.2021.716424","article-title":"Case report: the genetic diagnosis of Duchenne muscular dystrophy in the Middle East","volume":"9","author":"Alghamdi","year":"2021","journal-title":"Front Pediatr"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"103562","DOI":"10.1016\/j.ejmg.2018.10.014","article-title":"Inherited metabolic disorders in adults: a view from Saudi Arabia","volume":"62","author":"Sulaiman","year":"2019","journal-title":"Eur J Med Genet"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ymgme.2017.04.002","article-title":"A multicenter clinical exome study in unselected cohorts from a consanguineous population of Saudi Arabia demonstrated a high diagnostic yield","volume":"121","author":"Alfares","year":"2017","journal-title":"Mol Genet Metab"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00439-017-1821-8","article-title":"The landscape of genetic diseases in Saudi Arabia based on the first 1000 diagnostic panels and exomes","volume":"136","author":"Monies","year":"2017","journal-title":"Hum Genet"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.nmd.2014.03.008","article-title":"A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy","volume":"24","author":"Mah","year":"2014","journal-title":"Neuromuscul Disord"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13023-017-0631-3","article-title":"The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review","volume":"12","author":"Ryder","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/ana.23528","article-title":"Evidence-based path to newborn screening for duchenne muscular dystrophy","volume":"71","author":"Mendell","year":"2012","journal-title":"Ann Neurol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1006\/geno.1993.1225","article-title":"Exon structure of the human dystrophin gene","volume":"16","author":"Roberts","year":"1993","journal-title":"Genomics"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/0888-7543(92)90437-W","article-title":"Construction of a 2.6-Mb contig in yeast artificial chromosomes spanning the human dystrophin gene using an STS-based approach","volume":"12","author":"Coffey","year":"1992","journal-title":"Genomics"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/S0140-6736(11)60756-3","article-title":"Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study","volume":"378","author":"Cirak","year":"2011","journal-title":"Lancet"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/jhg.2016.152","article-title":"Comparison of the phenotypes of patients harboring in-frame deletions starting at exon 45 in the Duchenne muscular dystrophy gene indicates potential for the development of exon skipping therapy","volume":"62","author":"Nakamura","year":"2017","journal-title":"J Hum Genet"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/humu.22758","article-title":"The TREAT-NMD DMD global database: analysis of more than 7,000 duchenne muscular dystrophy mutations","volume":"36","author":"Bladen","year":"2015","journal-title":"Hum Mutat"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/mus.20586","article-title":"Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule","volume":"34","author":"Aartsma-Rus","year":"2006","journal-title":"Muscle Nerve"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/jhg.2016.28","article-title":"Deletion of exons 3-9 encompassing a mutational hot spot in the DMD gene presents an asymptomatic phenotype, indicating a target region for multiexon skipping therapy","volume":"61","author":"Nakamura","year":"2016","journal-title":"J Hum Genet"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"e108038","DOI":"10.1371\/journal.pone.0108038","article-title":"Screening of Duchenne muscular dystrophy (DMD) mutations and investigating its mutational mechanism in Chinese patients","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3349\/ymj.2017.58.3.613","article-title":"Multiplex ligation-dependent probe amplification in X-linked recessive muscular dystrophy in Korean subjects","volume":"58","author":"Suh","year":"2017","journal-title":"Yonsei Med J"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"58","DOI":"10.4103\/0028-3886.152635","article-title":"A comparative study of mPCR, MLPA, and muscle biopsy results in a cohort of children with Duchenne muscular dystrophy: a first study","volume":"63","author":"Manjunath","year":"2015","journal-title":"Neurol India"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S1016-8478(23)24500-8","article-title":"Frameshift deletion mechanisms in Egyptian Duchenne and Becker muscular dystrophy families","volume":"18","author":"Elhawary Nasser","year":"2004","journal-title":"Mol Cells"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1155\/S1110724302205069","article-title":"Analysis of dystrophin gene deletions by multiplex PCR in Moroccan patients","volume":"2","author":"Sbiti","year":"2002","journal-title":"J Biomed Biotechnol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.clinbiochem.2010.03.014","article-title":"Combination of conventional multiplex PCR and quantitative real-time PCR detects large rearrangements in the dystrophin gene in 59% of Syrian DMD\/BMD patients","volume":"43","author":"Madania","year":"2010","journal-title":"Clin Biochem"},{"key":"ref36","first-page":"1478","article-title":"Deletion mutations in the dystrophin gene of Saudi patients with Duchenne and Becker muscular dystrophy","volume":"23","author":"Al-Jumah","year":"2002","journal-title":"Saudi Med J"},{"key":"ref37","first-page":"16","article-title":"Mutation analysis in Saudi Duchenne and Becker muscular dystrophy patients using multiplex PCR","volume":"4","author":"Chaudhary","year":"2008","journal-title":"Arch Med Sci"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.sjbs.2010.04.008","article-title":"Deletion mutations in Duchenne muscular dystrophy (DMD) in Western Saudi children","volume":"17","author":"Tayeb","year":"2010","journal-title":"Saudi J Biol Sci"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40246-018-0152-8","article-title":"Molecular characterization of exonic rearrangements and frame shifts in the dystrophin gene in Duchenne muscular dystrophy patients in a Saudi community","volume":"12","author":"Elhawary","year":"2018","journal-title":"Hum Genomics"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S1474-4422(09)70272-8","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care","volume":"9","author":"Bushby","year":"2010","journal-title":"Lancet Neurol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S1474-4422(09)70271-6","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management","volume":"9","author":"Bushby","year":"2010","journal-title":"Lancet Neurol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1020059","DOI":"10.3389\/fped.2022.1020059","article-title":"Patient demographics and characteristics from an ambispective, observational study of patients with duchenne muscular dystrophy in Saudi Arabia","volume":"10","author":"AlSaman","year":"2022","journal-title":"Front Pediatr"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1136\/hrt.2007.125948","article-title":"Life expectancy and death from cardiomyopathy amongst carriers of Duchenne and Becker muscular dystrophy in Scotland","volume":"94","author":"Holloway","year":"2008","journal-title":"Heart"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2217\/nmt-2019-0002","article-title":"Current management of Duchenne muscular dystrophy in the Middle East: expert report","volume":"9","author":"Al Jumah","year":"2019","journal-title":"Neurodegener Dis Manag"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.pedneo.2017.02.004","article-title":"The natural history of the patients with Duchenne muscular dystrophy in Taiwan: a medical center experience","volume":"59","author":"Liang","year":"2018","journal-title":"Pediatr Neonatol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnins.2022.992546","article-title":"Clinical and genetic characteristics of Chinese Duchenne\/Becker muscular dystrophy patients with small mutations","volume":"16","author":"Gan","year":"2022","journal-title":"Front Neurosci"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0255011","article-title":"Clinical and genetic spectra in patients with dystrophinopathy in Korea: a single-center study","volume":"16","author":"Yun","year":"2021","journal-title":"PLoS One"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.jiph.2019.06.001","article-title":"National screening programs in Saudi Arabia: overview, outcomes, and effectiveness","volume":"12","author":"Gosadi","year":"2019","journal-title":"J Infect Public Health"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/mus.24332","article-title":"Ataluren treatment of patients with nonsense mutation dystrophinopathy","volume":"50","author":"Bushby","year":"2014","journal-title":"Muscle Nerve"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1392274\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:27:54Z","timestamp":1721176074000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1392274\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,17]]},"references-count":49,"alternative-id":["10.3389\/fneur.2024.1392274"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2024.1392274","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,17]]},"article-number":"1392274"}}